Editorial: Cell therapy, liver diseases, and regeneration
Front Cell Dev Biol
.
2022 Sep 5:10:999305.
doi: 10.3389/fcell.2022.999305.
eCollection 2022.
Authors
Wencheng Zhang
1
2
3
,
Guido Carpino
4
,
Kirk J Wangensteen
5
,
Hexin Yan
6
,
Zhiying He
1
2
3
Affiliations
1
Institute for Regenerative Medicine, Shanghai East Hospital, School of Life Sciences and Technology, Tongji University, Shanghai, China.
2
Shanghai Engineering Research Center of Stem Cells Translational Medicine, Shanghai, China.
3
Shanghai Institute of Stem Cell Research and Clinical Translation, Shanghai, China.
4
Department of Movement, Human and Health Sciences, University of Rome "Foro Italico", Rome, Italy.
5
Department of Medicine, Division of Gastroenterology and Hepatology, Mayo Clinic, Rochester, MN, United States.
6
Renji Hospital Affiliated to Shanghai Jiaotong University, School of Medicine, Shanghai, China.
PMID:
36133918
PMCID:
PMC9483840
DOI:
10.3389/fcell.2022.999305
No abstract available
Keywords:
animal models; cell therapy; cell tracking/imaging; liver dieases; liver regeneration.
Publication types
Editorial